Abstract. Hyperoxaluria can lead to multiple pathologic conditions such as recurrent urolithiasis, oxalosis, nephrocalcinosis and even renal failure, but there is no known oxalate-degrading pathway in the human body, and current therapeutic options for patients with hyperoxaluria are limited. Oxalyl-CoA decarboxylase and formyl-CoA transferase are the key enzymes in the oxalate catabolism of Oxalobacter formigenes which dwell in the intestine of vertebrates and have an important symbiotic relationship with their hosts. The aim of this study was to insert the oxalate-degrading enzyme genes into human embryo kidney (HEK) 293 cells and to evaluate if the oxalate-degrading enzymes could be expressed in these cells and keep their enzyme activity. We present here the cloning of the two genes from O. formigenes and their subsequent expression in HEK293 cells. The results showed that the expression of oxalyl-CoA decarboxylase and formyl-CoA transferase was confirmed by RT-PCR and Western blotting, and the proteins were located in the cytoplasm of transfected cells. Furthermore, the transfected cells were capable to a certain degree of degrading oxalate. These findings suggest that the transfer of oxalate-degrading enzyme genes into human cells is possibly a potential candidate for the gene therapy of hyperoxaluria.
Introduction
Oxalate is a highly toxic natural by-product of normal cellular metabolism and is ingested with many common foods and beverages such as tea, coffee, chocolate, fruits, and vegetables (1) . There are several distinct mechanisms for oxalate catabolism present in nature, but unfortunately no oxalatedegrading pathway has been found in the human body. The abnormal synthesis of oxalate, mainly in the liver, or hyperabsorption in the gut can lead to the accumulation of oxalate in vivo and can result in a disorder in oxalate metabolism, hyperoxaluria. Hyperoxaluria can bring about multiple pathologic conditions such as recurrent urolithiasis, oxalosis, nephrocalcinosis and even early renal failure (2) . In patients with hyperoxaluria, current therapeutic options are limited and do not always lead to adequate success towards sufficiently decreasing the oxalate synthesis in the liver and reducing the oxalate excretion through the urinary system.
Recent evidence suggests that oxalate-degrading microorganisms dwelling in the gut, in particular Oxalobacter formigenes, have an important symbiotic relationship with their hosts by degrading oxalate and regulating oxalate absorption in the intestine (3) . The absence of O. formigenes is believed to increase the risk of recurrent calcium oxalate stones (4) . O. formigenes is a group of obligate anaerobic bacterium utilizing oxalate as its exclusive source of energy, which was characterized and first named by Allison et al in 1985 (5) . Initially, O. formigenes were isolated from the rumen (6) , the large bowel of herbivores (7), freshwater lake sediments (8) , and human feces (5) . They are similar in that they are all gram-negative, obligately anaerobic, nonmotile, rod-shaped, but are different in cellular fatty acid composition and serologic reaction, by which they are divided into several groups and strains (5) .
Oxalyl-CoA decarboxylase (OXC) and formyl-CoA transferase (FRC), which are encoded by the oxc and frc genes, are key enzymes in the oxalate metabolism of O. formigenes and were first purified by Baetz and Allison in 1989 (9) and 1990 (10), respectively. Oxalate can be metabolized to produce CO 2 and formate in a two-step enzymatic reaction catalyzed by OXC and FRC (11) . If human cells can gain the capacity of oxalate metabolism by the transgene of oxc and frc, there will be a promising new therapy option for hyperoxaluria. But oxc and frc are prokaryotic genes generally expressed in bacteria, and it is yet uncertain whether the oxc and frc genes can be expressed in eukaryocytes and still reserve the oxalate-degrading enzyme activity. In the present study, we constructed eukaryotic expression vectors containing the coding sequence of the oxc or frc genes labeled by an EGFP gene, and we stably transfected human embryo kidney 293 cells (HEK293) with these vectors. Moreover, the expression and enzyme activity of OXC and FRC in HEK293 cells were determined by a series of assays.
Materials and methods
Bacteria. The strain was isolated from fecal samples of healthy Chinese (data not shown). The anaerobic culture methods described by Allison (5) and Dawson (6) were employed. The strain was named OxCF and kept at the urologic laboratory of Tongji hospital at -80˚C.
PCR for oxc and frc genes. The genomic DNA, as a template for following PCR amplification, was extracted from OxCF cells using a Takara bacterial genomic DNA extraction kit (Takara, Dalian, P.R. China). According to the nucleotide sequence of the oxc and frc genes which were sequenced in our previous work, two pairs of oligonucleotide primers were synthesized as follows: the oxc gene, forward primer (5' GG AATTCGATGAGTAACGACGAC 3') reverse primer (5' C GGGATCCAATTTCTTGCCAACT 3'); and the frc gene, forward primer (5' CGGAATTCGATGACTAAACCAT 3'), reverse primer (5' CGGGATCCGAAACTACCTGTTT 3'). EcoRI and BamHI restriction sites were incorporated into the 5' end of the forward and reverse primers, respectively. PCR was carried out for one cycle at 95˚C for 5 min, followed by 35 cycles of 30 sec at 95˚C, 30 sec at 55˚C, and 60 sec at 72˚C and another 10 min at 72˚C for extension. The products were electrophoresed in 1% agarose gel for documentation.
Construction of eukaryotic expression vector.
The eukaryotic expression vector pEGFP-N1 (Clontech, USA) was employed to subclone the genes of interest. The plasmids and PCR products were digested with EcoRI and BamHI restriction enzymes and then size separated by electrophoresis. Separated DNA fragments of pEGFP (4.7 kb), oxc (1.7 kb) and frc (1.3 kb) were extracted from gel slices and then ligated overnight respectively. Recombinant plasmids were identified by EcoRI and BamHI restriction enzyme digestion and DNA sequencing. The successfully constructed expression vectors were named pEGFP-oxc and pEGFP-frc.
Gene transfer and cell culture. HEK293 cells (ATCC, USA) were employed to express the oxc and frc genes transferred by lipofection. HEK293 cells were seeded onto 24-well plates at a density of 1x10 5 cells per well. After 24 h of incubation, transfection was performed by Lipofectamine™ 2000 (Invitrogen, USA) according to the manufacturer's instructions. Plasmids (0.8 μg) (pEGFP-oxc, pEGFP-frc or pEGFP) and 2.0 μl liposome were involved in the procedure of lipofection for one well. After 48 h of culture, the transfected HEK293 cells were cultured with 800 μg/ml G418 (Gibco, USA) for 2 weeks and then 400 μg/ml for 3 weeks. Green fluorescence was observed under a fluorescence inverted microscope, and the percentage of EGFP-positive cells detected at 48 h reflected the transfection efficiency of the cells.
RT-PCR analysis. Total RNA (2 μg) was applied to synthesize cDNA by a one-step RT-PCR kit (Promega, USA) according to the manufacturer's instructions, and then 1 μl cDNA was used as the template for subsequent PCR amplification. After 5 min at 95˚C, 30 cycles of PCR with parameters of 95˚C for 30 sec, 50˚C for 30 sec, and 72˚C for 60 sec, followed by a final extension at 72˚C for 10 min, was performed to amplify cDNA of ß-actin, oxc and frc genes. Three pairs of oligonucleotide primers were synthesized as follows: ß-actin, forward primer (5' GCGGCTACAGCTT CACCACCA 3'), reverse primer (5' CGCCGATCCACACG GAGTACT 3'); the oxc gene, forward primer (5' GGCCAG ACCATTTCCGTAGAA 3'), reverse primer (5' TGCTGCA TCAGCCAGTTCAGA 3'); and the frc gene, forward primer (5' GCACTGGACCGTATGGGCTTT 3'), reverse primer (5' CGGTTTTGTGACGCATTTCCA 3'). The PCR products were 441, 347 and 271 bp, respectively.
Western blot analysis. The total proteins (50 μg) harvested from each sample were subjected to a 10% SDS-PAGE gel electrophoresis for 2 h and then electrotransferred to a nitrocellulose membrane. Blocked with 5% skimmed milk for 1 h, the membrane was probed with a primary rabbit polyclonal antibody against EGFP (1:100, sc-8334, Santa Cruz, USA) and a primary rabbit polyclonal antibody against human ß-actin (1:500, sc-1616-R, Santa Cruz) and diluted in TBST overnight at 4˚C. After being washed three times for 10 min each, the membrane was incubated with horseradish peroxidase-conjugated secondary antibody for 1 h at 37˚C. After being washed again, it was reacted with enhanced chemiluminescence reagent (Pierce, USA), wrapped with film and exposed.
Transfer of CoA. The enzyme activity of recombinant FRC was estimated by determining the change of oxalate concentration in the medium. Formyl-CoA was prepared by previously described procedures (12) . Sodium oxalate (Sigma-Aldrich, USA) and formyl-CoA were dissolved in PBS and filtered to sterilize, respectively. HEK293, HEK293/ pEGFP-frc and HEK293/pEGFP cells were seeded onto 7 wells in 24-well plates at a density of 5x10 4 cells per well respectively. After 48 h of culture at 37˚C, the medium was replaced with DMEM supplemented with 100 μmol/l sodium oxalate and 200 μmol/l formyl-CoA. The latter was collected at different time points (0, 3, 6, 9, 12, 15, 18, 21, and 24 h) and filtered by a 0.2-μm membrane. Then the filtrate was injected into a DX-80 ion chromatograph (Dionex, USA) to determine the concentration of oxalate or a Symmetry C 18 analytical column (3.9x150 mm, 5 μm) to measure the concentration of oxalyl-CoA.
Decarboxylation of oxalyl-CoA. The enzyme activity of recombinant OXC was estimated by determining the change in oxalyl-CoA concentration in the medium. Oxalyl-CoA was prepared by previously described procedures (12, 13) and dissolved in PBS. Then the solution was filtered to sterilize and added to DMEM. HEK293, HEK293/pEGFP-oxc and HEK293/pEGFP cells were seeded into 7 wells in 24-well plates at a density of 5x10 4 cells per well respectively. After 48 h, the medium was replaced with DMEM containing 100 μmol/l oxalyl-CoA and then the latter was collected at different time points (0, 3, 6, 9, 12, 15, 18, 21, and 24 h). Subsequently, 200 μl of the fluid was passed through a 0.2-μm-pore-size filter and injected onto a Symmetry C 18 analytical column (3.9x150 mm, 5 μm) to determine the concentration of oxalyl-CoA by a reverse-phase highperformance liquid chromatograph (Waters, USA) using a modified procedure for analyzing CoA derivatives (12, 14) .
Statistical analysis. All experiments were repeated 5 times. The statistical software package SPSS 12.0 was used to analyze the data. The χ 2 test was performed to compare frequencies among the groups. P values <0.05 were considered statistically significant.
Results
Stable transfection with pEGFP-oxc and pEGFP-frc in the HEK293 cells. pEGFP-oxc, pEGFP-frc and control plasmids were transferred into HEK293 cells by lipofection followed by selective culture respectively. Six hours after transfection, slight green fluorescence was visible in these cells using 488-nm blue laser excitation light under a fluorescence inverted microscope. The cells were grown for 2 days in nonselective medium and then trypsinized followed by seeding into 6-well plates under a selective pressure of 800 μg/ml G418. At 24 and 48 h after transfection, bright green fluorescence was observed from a few cells scattered throughout the wells, and the transfection efficiency at 48 h of pEGFP- oxc, pEGFP-frc and the control plasmids was 23.5, 21.3 and 35.7%, respectively. After 3 days of G418-selective culture, several fluorescent cell colonies formed and a few nonfluorescent cells were scattered in the colonies. To achieve a pure and stably transfected cell line, the single colonies of cells were picked out and seeded again at a diluted density every 3 days for 2 weeks. Subsequently, selected cells were proliferated under a selective pressure of 400 μg/ml G418 for 3 weeks. At this time almost all cells exhibited bright green fluorescence as shown in Fig. 1A .
Localization and expression of the recombinant oxc and frc genes in the transfected HEK293 cells.
In the stably transfected HEK293 cells, the results reported by green fluorescence showed that the fusion proteins were located in the cytoplasm (Fig. 1B) . RT-PCR and Western blotting were performed to confirm the expression of the recombinant oxc and frc genes. Compared with the HEK293 cells transfected with the control plasmids, certain oxc or frc mRNA expression in HEK293 cells transfected with pEGFP-oxc or pEGFP-frc was demonstrated by RT-PCR respectively (Fig. 2A) . The sizes of amplified fragments were equal to those of the positive controls directly amplified from recombinant vectors. Protein immunoblot analysis was performed with an anti-EGFP monoclonal antibody. As shown in Fig. 2B and C, expression of EGFP (27 kDa) and fusion protein OXC (92 kDa) or FRC (71 kDa) was detected in cells transfected with control plasmids pEGFP-oxc and pEGFP-frc, respectively.
The transfer of CoA from formyl-CoA to oxalate by the cells transfected with pEGFP-frc.
To confirm if the FRC expressed in the HEK293 cells retained its enzyme activity capable of transferring CoA from formyl-CoA to oxalate, the concentration of oxalate and oxalyl-CoA in the medium was detected for 24 h. As shown in Fig. 3A and B, the concentration of oxalate in the medium of HEK293 cells transfected with pEGFP-frc exhibited a prominent decrease, and the concentration of oxalyl-CoA exhibited a corresponding increase, but there was no significant shift observed in the medium of HEK293 and HEK293/pEGFP cells.
The decarboxylation of oxalyl-CoA by the cells transfected with pEGFP-oxc.
The decarboxylation of oxalyl-CoA to formyl-CoA was catalyzed by OXC of O. formigenes, but it was uncertain whether the recombinant OXC expressed in the HEK293 cells retained its enzyme activity. An assay was designed to identify the activity of recombinant OXC by measuring the concentration of oxalyl-CoA throughout a 24-h culture period by a reverse-phase high-performance liquid chromatograph. Results shown in Fig. 3C confirmed a significant decrease of oxalyl-CoA in the medium of HEK293 cells transfected with pEGFP-oxc.
Discussion
In the 1980's, O. formigenes, an oxalate-degrading bacterium dwelling in the gut of humans and herbivores, was identified by Allison et al (5, 7, 15) . O. formigenes is a group of gramnegative, obligately anaerobic, nonmotile, rod-shaped bacteria dwelling especially in the colon and considered absolutely dependent on oxalate metabolism for energy. Many researchers believe that O. formigenes may play an important role in regulating dietary oxalate absorption of the digestive system and are closely related to urinary stone formation in humans (15) (16) (17) . Because they are abundant in the normal human colon (10 7 per gram feces) and rates of oxalate degradation by feces range from 0.1-4.8 nmol/(g x h) (15) , O. formigenes may digest enough oxalate to reduce intestinal absorption and corresponding urinary excretion of oxalate. It has been suggested that O. formigenes have an important symbiotic relationship with their hosts by degrading oxalate and regulating oxalate absorption in the intestine (3, 18) . Further studies indicated that there were less O. formigenes detected in the feces of calcium oxalate stone patients than that of normal individuals, and lack of O. formigenes might be an important risk factor for urinary stone formation (19, 20) . In addition, O. formigenes is probably antibiotic sensitive, and repeated antibiotic therapies could eradicate it. Thus the use of antibiotics may contribute to the loss of O. formigenes (16, 21) .
The decarboxylated degradation of oxalate in O. formigenes is a two-step enzymatic reaction catalyzed by OXC and FRC transferase (9, 10) . In this anaerobic metabolic procedure, one molecule of oxalate is decarboxylated to form one molecule of CO 2 and one molecule of formate, which is coupled with ATP synthesis (22) . FRC is encoded by the frc gene and catalyzes a transfer of CoA from formate to oxalate (10), which is necessary for the activation of oxalate before its decarboxylation, while OXC is encoded by the oxc gene and mediates an oxalyl moiety for thiamine-dependent decarboxylation to form formyl-CoA and liberate CO 2 (9) . The recombinant genes of the two key enzymes were heterologously expressed in Escherichia coli, and the products exhibited enzyme activity similar to the native enzymes (23) (24) (25) .
OXC and FRC expressed in a foreign environment retain their oxalate-degrading enzyme activity. Therefore, if the two key enzymes can retain their enzyme activity in mammalian cells, especially in human cells, there will exist a promising new therapy option for hyperoxaluria by transferring oxalatedegrading enzyme genes from O. formigenes into patients. Such studies were initiated by Lung et al in 1991 (23) , but much further research is still required such as determining if the oxalate-degrading enzyme genes can be transferred into human cells and retain their enzyme activity in vitro. In this study, we presented the cloning of the OXC and FRC genes of O. formigenes and their subsequent expression in HEK293 cells.
In our study, a eukaryotic expression vector pEGFP-N1 was employed to subclone the frc and oxc genes, respectively. pEGFP is a common vector for eukaryotic expression of exogenous genes and encodes enhanced green fluorescent protein (EGFP), a mutant of wild-type GFP, which has been optimized for brighter fluorescence and higher expression in mammalian cells (26) . EGFP is considered a rapid and sensitive reporter gene as a biological marker and the proteins which fuse to the N-terminus of EGFP gain fluorescent property while always retaining their native function (27) . We amplified the oxc and frc genes from genomic DNA extracted from OxCF, an O. formigenes strain, from the fecal samples of healthy Chinese and then inserted the gene fragments into pEGFP respectively. Subsequently, the recombinant plasmids which carried the oxc or frc gene as fusion to the N-terminus of EGFP were transferred to HEK293 cells by lipofection respectively. At 48 h after transfection, the transfection efficiency of pEGFPoxc and pEGFP-frc reported by green fluorescence was 23.5 and 21.3%, compared with 35.7% of the control plasmids. After 5 weeks of G418-selective culture, almost all cells exhibited bright green fluorescence, which indicated stable transfection and expression of the three plasmids.
In most cases the resultant chimera of EGFP and the tagged protein does not affect the activity of the latter (27) . Another purpose of EGFP in this study included its use as fusion tags of OXC and FRC. The fluorescence of HEK293 cells transfected with pEGFP-oxc or pEGFP-frc showed that the fusion proteins were located in the cytoplasm. Since there is no commercial antibody of OXC and FRC, we applied an antibody against EGFP to perform the Western blot analysis of the fusion proteins. In some previous studies (9, 10) , the SDS-PAGE gel electrophoresis of FRC and OXC indicated their molecular weights of 44 and 65 kDa. Correspondingly, the molecular weights of the EGFP (27 kDa) fusion proteins are ~71 and 92 kDa. In this study, the total proteins of stably transfected HEK293 cells were subjected to a 10% SDS-PAGE gel electrophoresis and the results showed apparent bands corresponding to the predicted size of fusion proteins. Analysis of RT-PCR products by agarose gel electrophoresis further confirmed the expression of the recombinant oxc and frc genes in the stably transfected HEK293 cells.
Previous studies (23) (24) (25) showed heterologous expression of FRC and OXC in Escherichia coli. But it was still uncertain whether the FRC and OXC could retain their enzyme activity as exogenous proteins in human cells. There are several examples of the expression of prokaryotic genes in eukaryotes such as the LacZ (28) and G418-resistance genes (29) . The optima of FRC and OXC activity (37˚C, pH 6.5 to 7.5) (10) is similar to the homeostasis of the human. In this study, the change of oxalate and oxalyl-CoA concentration in the medium was documented for 24 h to ascertain whether the FRC and OXC recombinantly expressed in the HEK293 cells retained their enzyme activity capable of transferring CoA from formyl-CoA to oxalate or decarboxylate oxalyl-CoA to formyl-CoA. The results showed that the concentration of oxalate in the medium of HEK293 cells transfected with pEGFP-frc exhibiting a prominent decrease, and the concentration of oxalyl-CoA exhibited a corresponding increase, which indicated oxalate could be activated to oxalyl-CoA by recombinant FRC. In the medium of HEK293 cells transfected with pEGFP-oxc, there was a significant decrease in oxalyl-CoA, which indicated that oxalyl-CoA could be decarboxylated to formyl-CoA by recombinant OXC.
Accumulation of oxalate can result in hyperoxaluria, and severe hyperoxaluria always leads to oxalosis, nephrocalcinosis, recurrent urolithiasis, and even early renal failure (2). As treatment options for patients with hyperoxaluria especially primary hyperoxaluria are limited, new therapeutic approaches are still needed for these patients. This study provides evidence that recombinant OXC and FRC can be expressed in human cells and can keep their oxalatedegrading enzyme activity, which implies a potential candidate for the gene therapy of hyperoxaluria. However, further studies, such as experiments based on animal models in vivo, are clearly needed.
